GlaxoSmithKline
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Study to Evaluate the Immunogenicity and the Safety of an Adjuvanted Influenza Vaccine Candidate
- Conditions
- Influenza
- Interventions
- Biological: GSK1247446A GroupBiological: Fluarix™
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2018-06-08
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 150
- Registration Number
- NCT00363077
- Locations
- 🇧🇪
GSK Investigational Site, Gent, Belgium
Repeat Dose Study of Fluticasone Propionate/Salmeterol Versus Fluticasone Propionate + Salmeterol In Asthmatics
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2017-09-29
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 12
- Registration Number
- NCT00364442
- Locations
- 🇩🇪
GSK Investigational Site, Berlin, Germany
Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2017-01-18
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 302
- Registration Number
- NCT00363311
- Locations
- 🇨🇦
GSK Investigational Site, Trois Rivieres, Quebec, Canada
A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects
- Conditions
- HIV InfectionInfection, Human Immunodeficiency Virus
- Interventions
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2010-11-05
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 211
- Registration Number
- NCT00363142
- Locations
- 🇵🇷
GSK Investigational Site, San Juan, Puerto Rico
Results Of Patient Rated Asthma Control Test In Comparison To Diary Card Data
- Conditions
- Asthma
- Interventions
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2018-03-09
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 221
- Registration Number
- NCT00363480
- Locations
- 🇩🇪
GSK Investigational Site, Hamburg, Germany
Study of GW685698X In Patients With Seasonal Allergic Rhinitis
- Conditions
- Rhinitis, Allergic, Seasonal
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2018-08-31
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 38
- Registration Number
- NCT00363740
- Locations
GSK Investigational Site
A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome
- Conditions
- Restless Legs SyndromeRestless Legs Syndrome (RLS)
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2016-10-17
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 360
- Registration Number
- NCT00363857
- Locations
- 🇺🇸
GSK Investigational Site, Walla Walla, Washington, United States
To Assess Immunogenicity, Reactogenicity & Safety of 2 Formulations of GSK's HRV Vaccine as 2-dose Vaccination (Infants)
- Conditions
- Infections, Rotavirus
- Interventions
- Biological: Lyophilized formulation of HRV vaccineBiological: Liquid formulation of HRV vaccine
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2018-06-08
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 1274
- Registration Number
- NCT00363545
- Locations
- 🇵🇦
GSK Investigational Site, Panama, Panama
A Two-way Crossover Study Of The Effect Of Food On The Pharmacokinetics Of Pazopanib In Cancer Patients
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2017-11-17
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 28
- Registration Number
- NCT00363194
- Locations
- 🇺🇸
GSK Investigational Site, Detroit, Michigan, United States
A Study to Demonstrate the Efficacy of GSK Biologicals' Influenza Vaccine in Adults
- Conditions
- Influenza
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2017-03-23
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 7632
- Registration Number
- NCT00363870
- Locations
- 🇫🇮
GSK Investigational Site, Vantaa, Finland